Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous to U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

This site contains about 58,903 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   700   800   900   1,000   1,100   1,200   1,300   1,400   1,500   1,670   1,680   1,690   1,700   1,710   1,720   1,730   1,740   1,750   1,762   1,763   1,764   1,765   1,766   1,767   1,768   1,769   1,770   1,771   1,772   1,773   1,774   1,775   1,776   1,777   1,778   1,779   1,780   1,781   1,782   1,783   1,784   1,785   1,786   1,787   1,788   1,789   1,790   1,791   1,800   1,810   1,820   1,830   1,840   1,850   1,860   1,870   1,900   1,964 

2013/2/25
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
http://media.marketwire.com/attachments/201301/56000_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=989586&ProfileId=051205&sourceType=1 NEW YORK, NY --
View more U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous analysis
Sign-up for U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous investment picks
2013/2/21
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
http://media.marketwire.com/attachments/201301/56000_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=988490&ProfileId=051205&sourceType=1 NEW YORK, NY --
View more U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous analysis
Sign-up for U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous investment picks
2013/04/27
U.S. GDP Not as Good as the Report Suggests
The year-over-year data paints a very different picture than the quarter-to-quarter annualized data we got on Friday.
View more U.S. GDP Not as Good as the Report Suggests analysis
Sign-up for U.S. GDP Not as Good as the Report Suggests investment picks
2013/3/27
U.S. Global Announces Lower Shareholder Fees
U.S. Global Investors, Inc. ( Nasdaq: GROW ), a boutique registered investment adviser offering actively managed mutual funds for investors and financial advisors who seek alpha in gold, resources and emerging markets, announced improvements to benefit shareholders and help drive asset growth.
View more U.S. Global Announces Lower Shareholder Fees analysis
Sign-up for U.S. Global Announces Lower Shareholder Fees investment picks
2013/4/4
U.S. Global Finalizes Strategic Investment in Toronto-Based Galileo Global Equity Advisors Inc. which Manages Approximately CA$320 Million in Assets
U.S. Global Investors, Inc. ( Nasdaq: GROW ), a boutique registered investment adviser specializing in natural resources and emerging markets, announced today that the company has completed its agreement to purchase 50 percent of the issued and outstanding shares of Toronto-based Galileo Global Equity Advisors Inc. (Galileo). Effective March 31, 2013, Galileo’s President, CEO and Chief Investment Officer Michael Waring and U.S. Global each own 50 percent of the outstanding shares of Galileo.
View more U.S. Global Finalizes Strategic Investment in Toronto-Based Galileo Global Equity Advisors Inc. which Manages Approximately CA$320 Million in Assets analysis
Sign-up for U.S. Global Finalizes Strategic Investment in Toronto-Based Galileo Global Equity Advisors Inc. which Manages Approximately CA$320 Million in Assets investment picks
2013/5/1
U.S. Global Investors Announces Earnings Webcast
U.S. Global Investors, Inc. ( Nasdaq: GROW ) will host a webcast on Thursday, May 9, 2013, at 7:30 a.m. Central time to discuss the company’s earnings for the quarter ended March 31, 2013.
View more U.S. Global Investors Announces Earnings Webcast analysis
Sign-up for U.S. Global Investors Announces Earnings Webcast investment picks
2013/1/30
U.S. Global Investors Announces Earnings Webcast
U.S. Global Investors, Inc. ( Nasdaq: GROW ) will host a webcast on Thursday, February 7, 2013, at 7:30 a.m. Central time to discuss the company’s earnings for the quarter ended December 31, 2012.
View more U.S. Global Investors Announces Earnings Webcast analysis
Sign-up for U.S. Global Investors Announces Earnings Webcast investment picks
2013/3/20
U.S. Global Investors Continues GROW Dividends
U.S. Global Investors, Inc. ( Nasdaq: GROW ), a boutique registered investment adviser specializing in natural resources and emerging markets, will continue its payment of monthly dividends in the second calendar quarter of 2013.
View more U.S. Global Investors Continues GROW Dividends analysis
Sign-up for U.S. Global Investors Continues GROW Dividends investment picks
2013/2/6
U.S. Global Investors Reports Results for the Second Quarter of 2013 Fiscal Year
U.S. Global Investors, Inc. ( NASDAQ : GROW ), a boutique registered investment advisory firm specializing in natural resources and emerging markets, recorded net income of $165,985, or 1 cent per share, on revenues of $5.49 million for the quarter ended December 31, 2012.
View more U.S. Global Investors Reports Results for the Second Quarter of 2013 Fiscal Year analysis
Sign-up for U.S. Global Investors Reports Results for the Second Quarter of 2013 Fiscal Year investment picks
2013/5/8
U.S. Global Investors Reports Results for the Third Quarter of 2013 Fiscal Year
U.S. Global Investors, Inc. (NASDAQ: GROW) , a boutique registered investment advisory firm specializing in natural resources and emerging markets, recorded net income of $41,167, or 0 cents per share, on revenues of $4.77 million for the quarter ended March 31, 2013.
View more U.S. Global Investors Reports Results for the Third Quarter of 2013 Fiscal Year analysis
Sign-up for U.S. Global Investors Reports Results for the Third Quarter of 2013 Fiscal Year investment picks
2013/4/1
U.S. Groups Cut Billabong Bids Below A$1.10/Share
SYDNEY --Two U.S. consortia competing to acquire surfwear retailer Billabong International Ltd.
View more U.S. Groups Cut Billabong Bids Below A$1.10/Share analysis
Sign-up for U.S. Groups Cut Billabong Bids Below A$1.10/Share investment picks
2013/4/11
U.S. Health Care Providers Having Difficulty Recruiting Experienced IT Workers, Towers Watson Survey Finds
U.S. health care providers need to rethink their approach to hiring and retaining the experienced information technology (IT) professionals they need in the new health care environment, according to new research by global professional services company Towers Watson (NYSE, NASDAQ: TW). At a time when many are already struggling to compete with IT consultancies that can afford to pay top dollar for experienced IT professionals, providers are further disadvantaged by their own misconceptions about what IT workers actually want from an employer.
View more U.S. Health Care Providers Having Difficulty Recruiting Experienced IT Workers, Towers Watson Survey Finds analysis
Sign-up for U.S. Health Care Providers Having Difficulty Recruiting Experienced IT Workers, Towers Watson Survey Finds investment picks
2013/1/30
U.S. Health Care Spending Projected to Grow From $2.8 Trillion to $4.8 Trillion by 2021
http://media.marketwire.com/attachments/201301/56000_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=979808&ProfileId=051205&sourceType=1 NEW YORK, NY --
View more U.S. Health Care Spending Projected to Grow From $2.8 Trillion to $4.8 Trillion by 2021 analysis
Sign-up for U.S. Health Care Spending Projected to Grow From $2.8 Trillion to $4.8 Trillion by 2021 investment picks
2013/4/25
U.S. Home Value Appreciation Rate Slows in First Quarter, But Values in Some Local Markets Remain at a Boil
Unsustainably High Appreciation Continues in Phoenix, Las Vegas and California, But National Moderation Could Indicate Stabilization, According to First Quarter Zillow Real Estate Market Reports SEATTLE , April 25, 2013 /PRNewswire/ -- The national housing market showed signs of moderation in the first quarter after months of robust and largely unsustainable annual home value appreciation.
View more U.S. Home Value Appreciation Rate Slows in First Quarter, But Values in Some Local Markets Remain at a Boil analysis
Sign-up for U.S. Home Value Appreciation Rate Slows in First Quarter, But Values in Some Local Markets Remain at a Boil investment picks
2013/3/26
U.S. home-price growth at six-year high
WASHINGTON (MarketWatch) — U.S. home prices edged up in January to make the year-on-year improvement the fastest in more than six years, according to data released Tuesday.
View more U.S. home-price growth at six-year high analysis
Sign-up for U.S. home-price growth at six-year high investment picks
2013/2/27
U.S. Homebuilders Rally Continues in 2013 as Home Sales and Prices on the Rise
http://media.marketwire.com/attachments/201212/107982_FSE_Logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=990732&ProfileId=051205&sourceType=1 NEW YORK, NY --
View more U.S. Homebuilders Rally Continues in 2013 as Home Sales and Prices on the Rise analysis
Sign-up for U.S. Homebuilders Rally Continues in 2013 as Home Sales and Prices on the Rise investment picks
2013/4/9
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Tuesday's session are J.C. Penney Co.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/3
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Wednesday's session are Global Payments Inc. (GPN), Zynga Inc. (ZNGA) and ConAgra Foods Inc. (CAG). Global Payments' fiscal third-quarter earnings edged up 0.9% as the credit-card processor posted stronger revenue that helped offset higher costs.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/2
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Tuesday's session are BGC Partners Inc. (BGCP), Obagi Medical Products Inc. (OMPI) and Humana Inc. (HUM). NASDAQ OMX Group Inc. (NDAQ) agreed to acquire the eSpeed platform from BGC in a cash-and-stock deal worth as much as $1.23 billion as the exchange company seeks an entry into the electronic fixed-income business.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/4
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Thursday's session are CombiMatrix Corp.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/8
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Monday's session are Lufkin Industries Inc. (LUFK), Obagi Medical Products Inc. (OMPI) and Constellation Brands Inc. (STZ). General Electric Co.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/12
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Friday's session are Infosys Ltd.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/11
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade premarket are Hewlett-Packard Co.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/10
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Wednesday's session are Realogy Holdings Corp.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/17
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Wednesday's session are Bank of America Corp.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/16
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Tuesday's session are Coca-Cola Co.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/16
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Tuesday's session are Sarepta Therapeutics Inc. (SRPT), HCA Holdings Inc. (HCA) and Netgear Inc. (NTGR). Sarepta Therapeutics said the Food and Drug Administration will consider accelerated approval for its eteplirsen drug to treat Duchenne muscular dystrophy after it conducts a further review of additional data.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/19
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Friday's session are Vertex Pharmaceuticals Inc. (VRTX), Air Methods Corp.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/18
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Thursday's session are Select Comfort Corp.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
2013/4/24
U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Among the companies with shares expected to actively trade in Wednesday's session are Apple Inc. (AAPL), Edwards Lifesciences Corp.
View more U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH analysis
Sign-up for U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous to U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.